<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Lesson 16.3: The Metabolic-Gut Axis: Managing Resistant Weight Loss and Endotoxemia</title>
    <style>
        /* Base & Reset */
        * {
            box-sizing: border-box;
        }

        body {
            font-family: Georgia, 'Times New Roman', serif;
            line-height: 1.8;
            color: #2d2d2d;
            background: #f8f6f3;
            margin: 0;
            padding: 0;
        }

        /* Main Container */
        .lesson-container {
            max-width: 860px;
            margin: 0 auto;
            padding: 40px 30px;
            background: #ffffff;
            min-height: 100vh;
            box-shadow: 0 0 60px rgba(0, 0, 0, 0.08);
        }

        /* Brand Header */
        .brand-header {
            text-align: center;
            padding-bottom: 30px;
            margin-bottom: 35px;
            border-bottom: 1px solid #eee;
        }

        .brand-logo {
            max-width: 220px;
            height: auto;
            margin-bottom: 5px;
        }

        /* Module Header - GREEN theme for Gut Health */
        .module-header {
            background: linear-gradient(135deg, #059669 0%, #10B981 100%);
            padding: 35px 35px 30px;
            border-radius: 16px;
            margin-bottom: 30px;
            position: relative;
            overflow: hidden;
        }

        .module-header::before {
            content: '';
            position: absolute;
            top: 0;
            right: 0;
            width: 300px;
            height: 300px;
            background: radial-gradient(circle, rgba(255, 255, 255, 0.1) 0%, transparent 70%);
            transform: translate(100px, -100px);
        }

        .module-header::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 100%;
            height: 4px;
            background: linear-gradient(90deg, #B8860B, #D4A84B, #B8860B);
        }

        .module-label {
            margin: 0;
            font-size: 11px;
            color: rgba(255, 255, 255, 0.75);
            text-transform: uppercase;
            letter-spacing: 2.5px;
            font-weight: 500;
        }

        .lesson-title {
            margin: 10px 0 0 0;
            font-size: 28px;
            color: #ffffff;
            font-weight: 700;
            line-height: 1.3;
            position: relative;
        }

        .lesson-meta {
            display: flex;
            gap: 12px;
            margin-top: 20px;
            padding-top: 18px;
            border-top: 1px solid rgba(255, 255, 255, 0.15);
            flex-wrap: wrap;
        }

        .meta-item {
            display: flex;
            align-items: center;
            gap: 6px;
            font-size: 12px;
            color: rgba(255, 255, 255, 0.85);
            background: rgba(255, 255, 255, 0.1);
            padding: 5px 12px;
            border-radius: 4px;
        }

        /* Table of Contents */
        .toc-box {
            background: linear-gradient(135deg, #fafafa 0%, #f5f5f5 100%);
            border-radius: 14px;
            padding: 24px 28px;
            margin-bottom: 35px;
            border: 1px solid #e8e8e8;
        }

        .toc-box .box-label {
            font-weight: 600;
            color: #059669;
            margin: 0 0 18px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
            padding-bottom: 12px;
            border-bottom: 1px solid #e0e0e0;
        }

        .toc-list {
            list-style: none;
            margin: 0;
            padding: 0;
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 8px 24px;
        }

        .toc-list li {
            margin: 0;
        }

        .toc-list a {
            display: flex;
            align-items: center;
            padding: 8px 12px;
            color: #555;
            text-decoration: none;
            font-size: 14px;
            border-radius: 6px;
            transition: all 0.2s ease;
        }

        .toc-list a:hover {
            background: white;
            color: #059669;
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.06);
        }

        .toc-list .section-num {
            display: inline-flex;
            align-items: center;
            justify-content: center;
            width: 26px;
            height: 26px;
            background: #059669;
            color: white;
            font-weight: 600;
            font-size: 11px;
            border-radius: 6px;
            margin-right: 12px;
            flex-shrink: 0;
        }

        /* Learning Objectives */
        .objectives-box {
            background: #f0fdf4;
            border: 2px solid #10B981;
            border-radius: 14px;
            padding: 30px 35px;
            margin-bottom: 40px;
        }

        .objectives-box .box-label {
            font-weight: 600;
            color: #059669;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
            display: flex;
            align-items: center;
            gap: 10px;
        }

        .objectives-box .box-label::before {
            content: 'ðŸŽ¯';
            font-size: 18px;
        }

        .objectives-box ul {
            margin: 0;
            padding-left: 22px;
        }

        .objectives-box li {
            margin-bottom: 14px;
            font-size: 16px;
            line-height: 1.7;
        }

        /* Section Headings */
        h2 {
            font-size: 24px;
            color: #059669;
            margin: 50px 0 20px 0;
            font-weight: 600;
            position: relative;
            padding-bottom: 12px;
        }

        h2::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 60px;
            height: 3px;
            background: #B8860B;
        }

        h3 {
            font-size: 20px;
            color: #111;
            margin: 30px 0 15px 0;
            font-weight: 600;
        }

        /* Paragraphs & Text */
        p {
            font-size: 17px;
            margin-bottom: 20px;
            color: #333;
        }

        .highlight {
            background: linear-gradient(180deg, transparent 60%, #FFF59D 60%);
            padding: 0 4px;
            font-weight: 500;
        }

        /* Case Study Box */
        .case-study {
            background: linear-gradient(135deg, #f8f9fb 0%, #f0f2f5 100%);
            border-radius: 16px;
            padding: 0;
            margin: 40px 0;
            overflow: hidden;
            box-shadow: 0 4px 20px rgba(0, 0, 0, 0.06);
        }

        .case-study-header {
            background: linear-gradient(135deg, #059669 0%, #10B981 100%);
            padding: 20px 30px;
            display: flex;
            align-items: center;
            gap: 15px;
        }

        .case-study-icon {
            width: 45px;
            height: 45px;
            background: rgba(255, 255, 255, 0.15);
            border-radius: 10px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 22px;
        }

        .case-study-header .box-label {
            font-weight: 600;
            color: #ffffff;
            margin: 0;
            font-size: 16px;
        }

        .case-study-content {
            padding: 28px 30px;
        }

        .patient-profile {
            display: flex;
            align-items: center;
            gap: 18px;
            padding: 18px 22px;
            background: white;
            border-radius: 12px;
            margin-bottom: 20px;
            border: 1px solid #e5e5e5;
        }

        .patient-avatar {
            width: 55px;
            height: 55px;
            background: linear-gradient(135deg, #10B981, #059669);
            border-radius: 50%;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 24px;
            flex-shrink: 0;
        }

        /* Statistics Box */
        .stats-box {
            background: linear-gradient(135deg, #059669 0%, #10B981 100%);
            padding: 40px;
            border-radius: 16px;
            margin: 35px 0;
            position: relative;
            overflow: hidden;
        }

        .stats-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(140px, 1fr));
            gap: 25px;
            position: relative;
        }

        .stat-item {
            text-align: center;
        }

        .stat-number {
            font-size: 42px;
            font-weight: 700;
            color: white;
            line-height: 1;
            margin-bottom: 8px;
        }

        .stat-label {
            font-size: 13px;
            color: rgba(255, 255, 255, 0.85);
            text-transform: uppercase;
            letter-spacing: 1px;
        }

        /* Data Table */
        .data-table-container {
            margin: 35px 0;
            overflow-x: auto;
            border-radius: 12px;
            border: 1px solid #e5e5e5;
        }

        table {
            width: 100%;
            border-collapse: collapse;
            font-size: 15px;
            text-align: left;
        }

        th {
            background: #f1f8f1;
            color: #059669;
            padding: 15px;
            font-weight: 600;
            border-bottom: 2px solid #e5e5e5;
        }

        td {
            padding: 15px;
            border-bottom: 1px solid #eee;
            color: #444;
        }

        /* Check Understanding */
        .check-understanding {
            background: linear-gradient(135deg, #fdfbf7 0%, #f9f5ed 100%);
            border: 2px solid #B8860B;
            border-radius: 16px;
            padding: 32px;
            margin: 45px 0;
        }

        .question-item {
            background: white;
            border-radius: 12px;
            padding: 22px 24px;
            margin-bottom: 16px;
            border: 1px solid #e8e4dc;
        }

        .reveal-btn {
            background: #059669;
            color: white;
            border: none;
            padding: 10px 20px;
            border-radius: 8px;
            font-size: 14px;
            cursor: pointer;
            margin-top: 10px;
        }

        .answer-text {
            display: none;
            font-size: 14px;
            color: #2e7d32;
            margin-top: 15px;
            padding: 15px;
            background: #f0f8f0;
            border-radius: 8px;
        }

        /* Takeaways & References */
        .takeaways-box {
            background: #f5f5f5;
            padding: 25px;
            border-radius: 12px;
            margin-top: 40px;
        }

        .references-box {
            margin-top: 40px;
            padding-top: 20px;
            border-top: 1px solid #eee;
            font-size: 14px;
            color: #666;
        }

        .references-box h4 {
            color: #333;
            margin-bottom: 15px;
        }

        .references-box ul {
            list-style: none;
            padding: 0;
        }

        .references-box li {
            margin-bottom: 10px;
        }

        .lesson-footer {
            text-align: center;
            padding: 40px 0;
            color: #888;
            font-size: 13px;
        }

        @media (max-width: 768px) {
            .toc-list { grid-template-columns: 1fr; }
            .lesson-container { padding: 20px 15px; }
        }
    </style>
</head>

<body>
    <div class="lesson-container">
        <div class="brand-header">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="brand-logo">
        </div>

        <header class="module-header">
            <p class="module-label">Module 16: Advanced Case Studies</p>
            <h1 class="lesson-title">Lesson 3: The Metabolic-Gut Axis: Managing Resistant Weight Loss and Endotoxemia</h1>
            <div class="lesson-meta">
                <span class="meta-item">35 min read</span>
                <span class="meta-item">Lesson 3 of 4</span>
            </div>
        </header>

        <div class="toc-box">
            <p class="box-label">In This Lesson</p>
            <ul class="toc-list">
                <li><a href="#endotoxemia"><span class="section-num">1</span>The Science of Endotoxemia</a></li>
                <li><a href="#akkermansia"><span class="section-num">2</span>The Akkermansia Factor</a></li>
                <li><a href="#scfa-glp1"><span class="section-num">3</span>SCFA and Incretin Signaling</a></li>
                <li><a href="#case-study-1"><span class="section-num">4</span>Case Study: Elena (T2D & NAFLD)</a></li>
                <li><a href="#polyphenols"><span class="section-num">5</span>Targeted Polyphenol Modulation</a></li>
                <li><a href="#practitioner"><span class="section-num">6</span>The Method: Clinical Application</a></li>
            </ul>
        </div>

        <div class="objectives-box">
            <p class="box-label">Learning Objectives</p>
            <ul>
                <li>Quantify the impact of Lipopolysaccharides (LPS) on systemic insulin resistance and metabolic inflammation.</li>
                <li>Identify the role of <i>Akkermansia muciniphila</i> as a master regulator of the intestinal mucin layer.</li>
                <li>Analyze the SCFA-mediated pathways that stimulate GLP-1 and PYY for appetite regulation.</li>
                <li>Develop a polyphenol-rich intervention strategy for clients with "stalled" weight loss and NAFLD.</li>
                <li>Distinguish between caloric-restriction failure and microbial-driven metabolic dysfunction.</li>
            </ul>
        </div>

        <h2 id="endotoxemia">1. Metabolic Endotoxemia: The Silent Weight-Loss Saboteur</h2>
        <p>For decades, the weight loss narrative was dominated by the "Calories In vs. Calories Out" (CICO) model. However, as an AccrediPro certified coach, you must look deeper into why some clients remain <span class="highlight">metabolically rigid</span> despite strict adherence to caloric deficits. The answer often lies in <b>Metabolic Endotoxemia</b>.</p>
        
        <p>Metabolic endotoxemia is defined as a 2- to 3-fold increase in circulating levels of <span class="highlight">Lipopolysaccharides (LPS)</span>â€”endotoxins found in the outer membrane of Gram-negative bacteria. When the intestinal barrier is compromised (as discussed in Module 3), LPS translocates into the bloodstream, where it binds to Toll-Like Receptor 4 (TLR4) on immune cells and adipocytes.</p>

        <div class="stats-box">
            <div class="stats-grid">
                <div class="stat-item">
                    <div class="stat-number">35%</div>
                    <div class="stat-label">Reduction in Insulin Sensitivity via LPS</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">2-3x</div>
                    <div class="stat-label">Higher LPS in Obese vs Lean Subjects</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">70%</div>
                    <div class="stat-label">Of Immune System in the GALT</div>
                </div>
            </div>
        </div>

        <p>Once TLR4 is activated, it triggers a cascade of pro-inflammatory cytokines (TNF-Î±, IL-6), leading to systemic low-grade inflammation. Critically, this inflammation interferes with insulin signaling by promoting the phosphorylation of Insulin Receptor Substrate 1 (IRS-1), effectively "locking" fat cells and preventing the mobilization of stored energy.</p>

        <h2 id="akkermansia">2. The Akkermansia Factor: Sentinel of the Mucin Layer</h2>
        <p>One of the most significant discoveries in the metabolic-gut axis is the role of <i>Akkermansia muciniphila</i>. This unique bacterium resides in the mucus layer of the colon and accounts for 1â€“5% of the total microbial population in healthy adults. It is a <span class="highlight">mucin-degrading specialist</span>, but its activity actually stimulates the goblet cells to produce <i>more</i> mucus, creating a robust, thick barrier.</p>

        <p>In clients with resistant weight loss, <i>Akkermansia</i> levels are often nearly undetectable. A lack of this "sentinel" species leads to a thinning of the mucus layer, allowing LPS to reach the epithelial surface more easily. Research has shown that <i>Akkermansia</i> abundance is inversely correlated with body mass index (BMI), fasting glucose, and visceral adiposity.</p>

        <h3>Practical Strategies for Boosting Akkermansia</h3>
        <p>Since direct <i>Akkermansia</i> supplementation is often restricted by regulatory or shelf-stability issues, we focus on <b>Microbial Modulation</b> through "The Method" framework:</p>
        <ul>
            <li><b>Polyphenols:</b> Anthocyanins from berries and ellagitannins from pomegranate act as specific growth factors for <i>Akkermansia</i>.</li>
            <li><b>Fasting:</b> Periodic fasting (16:8 or 24-hour fasts) encourages <i>Akkermansia</i> to "clean" the mucin layer, promoting its regeneration.</li>
            <li><b>Specific Fibers:</b> Glucomannan and partially hydrolyzed guar gum (PHGG) have shown efficacy in increasing its population.</li>
        </ul>

        <h2 id="scfa-glp1">3. SCFA-Mediated Signaling: The Gut-Incretin Connection</h2>
        <p>The microbiome doesn't just affect weight through inflammation; it acts as a <span class="highlight">virtual endocrine organ</span>. When beneficial bacteria ferment prebiotic fibers, they produce Short-Chain Fatty Acids (SCFAs), primarily acetate, propionate, and butyrate.</p>

        <div class="data-table-container">
            <table>
                <thead>
                    <tr>
                        <th>Metabolite</th>
                        <th>Target Receptor</th>
                        <th>Metabolic Outcome</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td><b>Butyrate</b></td>
                        <td>GPR41 / GPR43</td>
                        <td>Stimulates GLP-1 secretion; improves insulin sensitivity.</td>
                    </tr>
                    <tr>
                        <td><b>Propionate</b></td>
                        <td>GPR41</td>
                        <td>Inhibits hepatic cholesterol synthesis; triggers PYY (satiety).</td>
                    </tr>
                    <tr>
                        <td><b>Acetate</b></td>
                        <td>Central Nervous System</td>
                        <td>Crosses blood-brain barrier to suppress hypothalamic appetite.</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <p><b>GLP-1 (Glucagon-Like Peptide-1)</b> is the hormone targeted by modern weight-loss medications (semaglutide). However, the gut microbiome provides a natural pathway for GLP-1 stimulation. Butyrate binds to G-protein coupled receptors (GPR41/43) on the L-cells of the intestinal epithelium, triggering the release of GLP-1 and PYY, which slow gastric emptying and signal fullness to the brain.</p>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">ðŸ‘¤</div>
                <div>
                    <p class="box-label">Case Study 3.1: The "Stalled" Metabolic Journey</p>
                    <p style="color: white; font-size: 13px; margin: 0;">Client: Elena, 54 | Condition: T2D, NAFLD, Resistant Obesity</p>
                </div>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div class="patient-avatar">E</div>
                    <div class="patient-info">
                        <h4>Elena, 54 Years Old</h4>
                        <p>BMI: 34.2 | HbA1c: 7.1% | Stalled weight loss for 9 months.</p>
                    </div>
                </div>
                <p><b>Presenting Symptoms:</b> Elena presented with persistent fatigue, "brain fog" after meals, and an inability to lose weight despite a 1,500-calorie Mediterranean diet. Her blood work showed elevated ALT/AST (liver enzymes) and high-sensitivity C-Reactive Protein (hs-CRP) of 4.2 mg/L, indicating systemic inflammation.</p>
                
                <p><b>Intervention (The Method):</b> 
                    Instead of further caloric restriction, we focused on the <b>Metabolic-Gut Axis</b>:
                    <ul>
                        <li><b>Phase 1:</b> Introduced 500mg Berberine (TID) to mimic metformin's microbial effects and activate AMPK.</li>
                        <li><b>Phase 2:</b> High-dose anthocyanin protocol (200g wild blueberries daily + pomegranate extract) to target <i>Akkermansia</i>.</li>
                        <li><b>Phase 3:</b> Supplemented with 5g PHGG daily to boost butyrate production.</li>
                    </ul>
                </p>
                
                <p><b>Outcomes:</b> After 12 weeks, Elena's hs-CRP dropped to 1.1 mg/L. Her "brain fog" resolved within 14 days. Most importantly, without reducing calories further, she lost 14 lbs, and her HbA1c improved to 6.4%. Her liver enzymes normalized, suggesting a reduction in NAFLD-associated inflammation.</p>
            </div>
        </div>

        <h2 id="polyphenols">4. Polyphenol Intervention: Berberine and Anthocyanins</h2>
        <p>In advanced gut coaching, we utilize <span class="highlight">Polyphenols</span> not just as antioxidants, but as powerful microbial modulators. Two compounds stand out for managing endotoxemia and resistant weight loss:</p>

        <h3>Berberine: The "Microbial Metformin"</h3>
        <p>Berberine is an alkaloid found in plants like Goldenseal and Barberry. Its metabolic effects are largely mediated through the gut. A 2022 meta-analysis confirmed that berberine significantly alters the Firmicutes/Bacteroidetes ratio and increases the abundance of butyrate-producing bacteria. It also directly inhibits the growth of LPS-producing Proteobacteria, thereby lowering the "endotoxin load" at the source.</p>

        <h3>Anthocyanins and Ellagitannins</h3>
        <p>These deep-pigment compounds (found in blackberries, raspberries, and pomegranate) are poorly absorbed in the small intestine. This is a clinical advantage, as they reach the colon intact, where they serve as a primary food source for <i>Akkermansia muciniphila</i>. By strengthening the mucin layer, these polyphenols prevent the translocation of LPS, effectively "sealing" the metabolic leak.</p>

        <h2 id="practitioner">5. The Method: Clinical Application for Weight Loss</h2>
        <p>When working with a client who is "stalled," follow this hierarchy of intervention based on the AccrediPro Methodology:</p>

        <div class="principle-card">
            <div class="principle-title">Step 1: Assess the Endotoxin Load</div>
            <p class="principle-text">Look for "Metabolic Red Flags": Elevated hs-CRP, high triglycerides, and post-prandial fatigue. If these are present, caloric restriction will likely fail until the gut barrier is addressed.</p>
        </div>

        <div class="principle-card">
            <div class="principle-title">Step 2: Fortify the Sentinel (Akkermansia)</div>
            <p class="principle-text">Introduce "Prebiotic Colors." Aim for 30+ different plant types per week, with a focus on red, blue, and purple pigments to stimulate the mucin-protective bacteria.</p>
        </div>

        <div class="principle-card">
            <div class="principle-title">Step 3: Leverage Incretin Signaling</div>
            <p class="principle-text">Optimize fiber intake to ensure adequate SCFA production. This provides the natural stimulus for GLP-1, reducing cravings and improving glucose disposal without pharmacological intervention.</p>
        </div>

        <div class="check-understanding">
            <p class="box-label">Check Your Understanding</p>
            <p class="box-subtitle">Test your knowledge of the Metabolic-Gut Axis.</p>

            <div class="question-item">
                <p class="question-text">1. How does Lipopolysaccharide (LPS) directly contribute to insulin resistance?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">LPS translocates into the blood and binds to TLR4 receptors on immune cells and adipocytes. This triggers pro-inflammatory cytokines that interfere with the phosphorylation of IRS-1, effectively blocking the insulin signaling pathway.</div>
            </div>

            <div class="question-item">
                <p class="question-text">2. Why is <i>Akkermansia muciniphila</i> considered a "gatekeeper" of metabolic health?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">It regulates the thickness and integrity of the intestinal mucin layer. By maintaining a robust barrier, it prevents the translocation of endotoxins (LPS) into systemic circulation, thereby reducing metabolic inflammation.</div>
            </div>
        </div>

        <div class="takeaways-box">
            <p class="box-label">Key Takeaways</p>
            <ul>
                <li><b>Resistant Weight Loss:</b> Often driven by metabolic endotoxemia rather than a lack of willpower or "broken" metabolism.</li>
                <li><b>The LPS Pathway:</b> LPS translocation triggers systemic low-grade inflammation, which is a primary driver of insulin resistance and NAFLD.</li>
                <li><b>Akkermansia's Role:</b> Increasing this bacterium via polyphenols and specific fibers is a critical strategy for restoring barrier function.</li>
                <li><b>Natural GLP-1:</b> SCFAs (especially butyrate) are potent stimulators of the incretin hormones GLP-1 and PYY.</li>
                <li><b>Clinical Priority:</b> In cases of T2D and obesity, focus on "sealing the gut" before aggressively cutting calories.</li>
            </ul>
        </div>

        <div class="references-box">
            <h4>References & Further Reading</h4>
            <ul>
                <li>Cani, P. D., et al. (2021). "Akkermansia muciniphila: keynote player in immune-metabolism." <i>Nature Reviews Gastroenterology & Hepatology.</i></li>
                <li>Zhang, L., et al. (2022). "Berberine and its role in modulating the gut microbiota in type 2 diabetes: A systematic review." <i>Frontiers in Pharmacology.</i></li>
                <li>Everard, A., et al. (2023). "Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity." <i>Proceedings of the National Academy of Sciences (PNAS).</i></li>
                <li>Saad, M. J., et al. (2020). "The Gut Microbiome and Type 2 Diabetes: Focus on the Metabolic-Gut Axis." <i>Endocrine Reviews.</i></li>
                <li>Rousseau, A., et al. (2022). "Metabolic endotoxemia: a potential target for the prevention of insulin resistance." <i>The Lancet Diabetes & Endocrinology.</i></li>
                <li>Zhao, L., et al. (2018). "Gut bacteria selectively promoted by dietary fibers alleviate type 2 diabetes." <i>Science.</i></li>
            </ul>
        </div>

        <footer class="lesson-footer">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="footer-logo">
            <p class="brand">AccrediPro Academy: Gut Health & Microbiome Certification</p>
            <p class="copyright">&copy; 2024 AccrediPro Academy. All rights reserved. Professional Use Only.</p>
        </footer>
    </div>
</body>

</html>